Responses in mantle cell lymphoma cells to SNS-032 depend on the biological context of each cell line.
Responses in mantle cell lymphoma cells to SNS-032 depend on the biological context of each cell line.
复制标题
DOI:
10.1158/0008-5472.can-09-3578
复制
发表时间:
2010-08-15
期刊:
影响因子:
11.2
通讯作者:
Plunkett W
中科院分区:
文献类型:
--
作者:
Chen R;Chubb S;Cheng T;Hawtin RE;Gandhi V;Plunkett W
SNS-032 is a potent inhibitor of cyclin-dependent kinases (Cdk) 2, 7 and 9 that regulate the cell cycle and transcription. Our studies in indolent primary chronic lymphocytic leukemia cells demonstrated that SNS-032 inhibited transcription, diminished the anti-apoptotic protein Mcl-1, and induced apoptosis. The present study focuses on evaluating this compound in four proliferating mantle cell lymphoma (MCL) lines (Jeko-1, Granta 519, Mino and SP-53). Consistent with its action against Cdk9 and Cdk7, SNS-032 inhibited the phosphorylation of RNA pol II in all 4 lines and blocked RNA synthesis. The transcripts and protein levels of short-lived proteins decreased, including cyclin D1 and Mcl-1. Cell growth was inhibited in a concentration-dependent manner in all lines. Apoptosis was induced in JeKo-1, Mino and SP-53 cells without disrupting cell cycle distribution. However, apoptosis was limited in Granta cells; rather, there was a significant reduction of clonogenic survival. SiRNA was used to specifically knock down Mcl-1 and cyclin D1 in JeKo-1 and Granta cells. Knocking down Mcl-1 induced significant apoptosis in Jeko-1 cells but not Granta cells. Reducing cyclin D1, rather than Mcl-1 was associated with loss of clonogenic survival in Granta cells. Thus, these results indicated that MCL cell lines have distinct mechanisms sustaining their survival, and the mechanism of action SNS-032 is dependent on the biological context of an individual line.